SEC Form 4 · accession 0000939767-18-000246
EXELIXIS, INC. · EXEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George A Scangos
Director
Period of report
Nov 29, 2018
Accepted (ET)
Dec 3, 2018 · 8:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000939767
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 29, 2018 | S | 6,500 | $20.00 | D | 1,505,481 | D | |
| Common StockF3 | Nov 30, 2018 | S | 8,500 | $20.00 | D | 1,496,981 | D | |
| Common StockF4 | Dec 3, 2018 | S | 40,000 | $21.16 | D | 1,456,981 | D | |
| Common StockF5 | holding | — | — | — | 8,963 | I | By Trust (JS) | |
| Common StockF6 | holding | — | — | — | 8,963 | I | By Trust (KS) | |
| Common StockF7 | holding | — | — | — | 5,669 | I | By 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018.
- F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.03. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.01. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
- F4Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.76 to $21.57. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
- F5Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Jennifer Scangos Trust.
- F6Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Katherine Scangos Trust.
- F7Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 28, 2018.